Literature DB >> 24213972

Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.

Patrizia Garbati1, Enrico Adriano, Annalisa Salis, Silvia Ravera, Gianluca Damonte, Enrico Millo, Maurizio Balestrino.   

Abstract

The creatine/phosphocreatine system carries ATP from production to consumption sites and buffers the intracellular content of ATP at times of energy deprivation. The creatine transporter deficiency syndrome is an X-linked disease caused by a defective creatine transporter into the central nervous system. This disease is presently untreatable because creatine lacking its carrier cannot cross neither the blood-brain barrier nor the cell plasma membranes. Possible strategies to cure this condition are to couple creatine to molecules which have their own carrier, to exploit the latter to cross biological membranes or to modify the creatine molecule to make it more lipophilic, in such a way that it may more easily cross lipid-rich biological membranes. Such molecules could moreover be useful for treatment of stroke or other ischemic brain syndromes of normal (transporter working) tissue. In this paper we tested four molecules in in vitro hippocampal slices experiments to investigate whether or not they had a neuroprotective effect similar to that of creatine. On two of them we also performed biochemical measurements to investigate whether or not they were able to increase the creatine and phosphocreatine content of the hippocampal slices with and without block of the transporter. We found that these molecules increase levels of creatine after block of the transporter, and significantly increased the levels of phosphocreatine. Both significantly increased the total creatine content in both conditions of active and blocked transporter. This shows that these molecules are capable of entering cells through biological membranes without using the creatine transporter. By contrast, neither of them was able to delay synaptic block during anoxia of normal (transporter functioning) tissue. We conclude that these compounds might possibly be useful for therapy of creatine transporter deficiency, but further research is needed to understand their possible role in anoxia/ischemia of normal tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24213972     DOI: 10.1007/s11064-013-1188-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

Review 1.  Structure and function of inhibitory glycine receptors.

Authors:  H Betz
Journal:  Q Rev Biophys       Date:  1992-11       Impact factor: 5.318

2.  High frequency of creatine deficiency syndromes in patients with unexplained mental retardation.

Authors:  L Lion-François; D Cheillan; G Pitelet; C Acquaviva-Bourdain; G Bussy; F Cotton; L Guibaud; D Gérard; C Rivier; C Vianey-Saban; C Jakobs; G S Salomons; V des Portes
Journal:  Neurology       Date:  2006-11-14       Impact factor: 9.910

3.  Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening.

Authors:  Angela Arias; Marc Corbella; Carmen Fons; Angela Sempere; Judit García-Villoria; Aida Ormazabal; Pilar Poo; Mercé Pineda; María Antonia Vilaseca; Jaume Campistol; Paz Briones; Teresa Pàmpols; Gajja S Salomons; Antonia Ribes; Rafael Artuch
Journal:  Clin Biochem       Date:  2007-08-10       Impact factor: 3.281

4.  Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship.

Authors:  M Balestrino; R Rebaudo; G Lunardi
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

Review 5.  Neuroprotective effects of creatine.

Authors:  M Flint Beal
Journal:  Amino Acids       Date:  2011-03-30       Impact factor: 3.520

6.  Improved reperfusion and neuroprotection by creatine in a mouse model of stroke.

Authors:  Konstantin Prass; Georg Royl; Ute Lindauer; Dorette Freyer; Dirk Megow; Ulrich Dirnagl; Gerda Stöckler-Ipsiroglu; Theo Wallimann; Josef Priller
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-14       Impact factor: 6.200

Review 7.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

8.  Glycine-gated chloride channels depress synaptic transmission in rat hippocampus.

Authors:  Weifeng Song; Siriporn C Chattipakorn; Lori L McMahon
Journal:  J Neurophysiol       Date:  2005-12-28       Impact factor: 2.714

9.  Protection of hippocampal slices from young rats against anoxic transmission damage is due to better maintenance of ATP.

Authors:  I S Kass; P Lipton
Journal:  J Physiol       Date:  1989-06       Impact factor: 5.182

10.  Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes.

Authors:  W Dai; S Vinnakota; X Qian; D L Kunze; H K Sarkar
Journal:  Arch Biochem Biophys       Date:  1999-01-01       Impact factor: 4.013

View more
  6 in total

Review 1.  The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Authors:  Elsa Ghirardini; Francesco Calugi; Giulia Sagona; Federica Di Vetta; Martina Palma; Roberta Battini; Giovanni Cioni; Tommaso Pizzorusso; Laura Baroncelli
Journal:  Genes (Basel)       Date:  2021-07-24       Impact factor: 4.096

2.  Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  J Daniel Sharer; Olaf Bodamer; Nicola Longo; Silvia Tortorelli; Mirjam M C Wamelink; Sarah Young
Journal:  Genet Med       Date:  2017-01-05       Impact factor: 8.822

Review 3.  Augmentation of Creatine in the Heart.

Authors:  Sevasti Zervou; Hannah J Whittington; Angela J Russell; Craig A Lygate
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

4.  Oxidative phosphorylation in creatine transporter deficiency.

Authors:  Shizhe Li; Simona Bianconi; Jan Willem van der Veen; An Dang Do; JoEllyn Stolinski; Kim M Cecil; Fady Hannah-Shmouni; Forbes D Porter; Jun Shen
Journal:  NMR Biomed       Date:  2020-09-29       Impact factor: 4.478

5.  Change in network connectivity during fictive-gasping generation in hypoxia: prevention by a metabolic intermediate.

Authors:  Andrés Nieto-Posadas; Ernesto Flores-Martínez; Jonathan-Julio Lorea-Hernández; Ana-Julia Rivera-Angulo; Jesús-Esteban Pérez-Ortega; José Bargas; Fernando Peña-Ortega
Journal:  Front Physiol       Date:  2014-07-23       Impact factor: 4.566

6.  Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency.

Authors:  Enrico Adriano; Annalisa Salis; Gianluca Damonte; Enrico Millo; Maurizio Balestrino
Journal:  Brain Sci       Date:  2022-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.